Dr. Finn is Professor and Chair of the School of Chemistry and Biochemistry and Professor in the School of Biological Sciences at the Georgia Institute of Technology. His expertise is in the area of click chemistry, bioconjugation, protein nanoparticle-based vaccine development, and biomolecular evolution. His current interests include the anti-carbohydrate and anti-peptide immune response, cleavable linkages and functional materials for drug delivery, the discovery and development of click reactions for organic and materials synthesis, and polyvalent interactions in drug targeting. Dr. Finn obtained his Ph.D. degree in 1986 from the Massachusetts Institute of Technology working with Professor K.B. Sharpless, followed by an NIH postdoctoral fellowship with Professor J.P. Collman at Stanford University. He joined the faculty of the University of Virginia in 1988, where his group studied and developed a variety of transition metal-mediated processes. Dr. Finn moved to the Department of Chemistry and The Skaggs Institute for Chemical Biology at The Scripps Research Institute in 1998, and then to Georgia Tech in 2013. He has published more than 250 peer-reviewed scientific papers, was the first recipient of the annual Scripps Outstanding Mentor Award, and was Editor-in-Chief of the journal ACS Combinatorial Science.